Technology
Superior Safety
Tunable Immunogenicity
Organ & Cell Specific Targeting
Controlled Biodegradability
Applications
Platform Status
Cancer Immunotherapy
Shingles
Plague
Malaria
Media
News
Publications
Careers
More
The Team
Contact
Robust data demonstrated suitability for a wide range of applications.
R&D Data
Preclinical Data
Phase I/II Data
Cancer
Targeted immunotherapy
Viral Infections
Influenza
Bacterial Infections
S. Aureus
Other
IBD
Clinical Validation
COVID-19
